SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-026990
Filing Date
2023-05-03
Accepted
2023-05-03 16:44:14
Documents
2
Period of Report
2023-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1602
2 POA DOCUMENT poa.txt EX-24 3597
  Complete submission text file 0001209191-23-026990.txt   6493
Mailing Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421
Business Address 1050 WALTHAM STREET, SUITE 302 LEXINGTON MA 02421 617-314-6297
Keros Therapeutics, Inc. (Issuer) CIK: 0001664710 (see all company filings)

IRS No.: 811173868 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address
Seth Alpna (Reporting) CIK: 0001721020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39264 | Film No.: 23884882